{
    "nctId": "NCT01139957",
    "briefTitle": "Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer",
    "officialTitle": "Prospective Study of Risk-Reducing Salpingo-Oophorectomy (RRSO) and Longitudinal CA-125 Screening Among Women at Increased Genetic Risk of Ovarian Cancer: Extended Follow-Up of Select GOG-0199 Study Participants",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Neoplasm, Primary Peritoneal Carcinoma",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1916,
    "primaryOutcomeMeasure": "Prospective incidence of ovarian cancer (including fallopian tube cancer), primary peritoneal cancer, breast cancer, and all cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Enrolled on GOG-0199\n\n  * Completed the original 5-year follow-up period OR is off-study due to pregnancy or development of a new cancer\n  * Completed the Off-Study form (Form Q0-0199 submitted via SEDES)\n  * No patients who were off-study before the end of the initial 5-year follow-up period (found to be ineligible or consent withdrawal)",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}